Delivery Order SPE2DB22D3301-SPE2DB24FX8LD
Award Date 1/10/24
Potential Completion Date 2/1/24
Potential Value $70K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,230,046 units of BOTOX 200 unit vials. The $11,642.60 contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,667,812 units of BOTOX 200 unit vials. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,158,439 units of BOTOX 200 unit vials, with a potential value of $3,492.78 and a completion date of January 12, 2024. Amerisourcebergen Drug Corp is providing these pharmaceutical products to support DLA Troop Support Medical facilities. No set-aside designation was used for this award. Amerisourcebergen Drug...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical division awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $5,821.30, is for the provision of 200 unit vials of the pharmaceutical product BOTOX. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,821.30 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,562,500 units of BOTOX 200 unit vials. The contract has a completion date of February 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a potential value of $999,999,999.00 and a performance period through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,288 units of BOTOX 200 UNIT VIALS. The award, valued at $40,749.10, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense, and has received multiple federal contract awards to supply medicines,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BOTOX 200 unit vials. The $3,492.78 order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor to DLA, providing a range of pharmaceutical products and medical supplies in support of military treatment...
- This is a $124,063.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,584,078 units of BOTOX 200 unit vials, with a period of performance through July 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,643.70 firm fixed-price delivery order is for 4,567,178,994 units of BOTOX 200 unit vials. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,095.80, is a delivery order for 4,567,094,075 units of BOTOX 200 unit vials. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract was not designated with a specific set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX8LDDelivery Order
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,301,729 units of BOTOX 200 unit vials. The contract is a firm fixed price delivery order with a potential value of $69,855.60 and a completion date of February 1, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is an experienced federal contractor, providing a range of pharmaceutical products and medical supplies to support Department of Defense programs. This contract is one of many the company has received from DLA Troop Support Medical to deliver critical care items for military treatment facilities.
Generated 4/10/24, 9:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.9k | 1/10/24 |